138 related articles for article (PubMed ID: 33761648)
1. Construction of a prognostic value model in papillary renal cell carcinoma by immune-related genes.
Wang L; Gu W; Ni H
Medicine (Baltimore); 2021 Mar; 100(12):e24903. PubMed ID: 33761648
[TBL] [Abstract][Full Text] [Related]
2. Identification of 4-genes model in papillary renal cell tumor microenvironment based on comprehensive analysis.
Luo L; Zhou H; Su H
BMC Cancer; 2021 May; 21(1):553. PubMed ID: 33993869
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of immune-related genes in clear cell renal cell carcinoma.
Wan B; Liu B; Huang Y; Yu G; Lv C
Aging (Albany NY); 2019 Dec; 11(23):11474-11489. PubMed ID: 31821170
[TBL] [Abstract][Full Text] [Related]
4. Three-gene risk model in papillary renal cell carcinoma: a robust likelihood-based survival analysis.
Wang Y; Yan K; Lin J; Wang J; Zheng Z; Li X; Hua Z; Bu Y; Shi J; Sun S; Li X; Liu Y; Bi J
Aging (Albany NY); 2020 Nov; 12(21):21854-21873. PubMed ID: 33154194
[TBL] [Abstract][Full Text] [Related]
5. Immune Cell Infiltration and Identifying Genes of Prognostic Value in the Papillary Renal Cell Carcinoma Microenvironment by Bioinformatics Analysis.
Liu T; Zhang M; Sun D
Biomed Res Int; 2020; 2020():5019746. PubMed ID: 32775427
[TBL] [Abstract][Full Text] [Related]
6. A construction and comprehensive analysis of ceRNA networks and infiltrating immune cells in papillary renal cell carcinoma.
Fan Y; Dai F; Yuan M; Wang F; Wu N; Xu M; Bai Y; Liu Y
Cancer Med; 2021 Nov; 10(22):8192-8209. PubMed ID: 34598322
[TBL] [Abstract][Full Text] [Related]
7. Identification and validation of ubiquitin-proteasome system related genes as a prognostic signature for papillary renal cell carcinoma.
Zhang X; Liu X; Xiong R; An HX
Aging (Albany NY); 2022 Nov; 14(23):9599-9616. PubMed ID: 36385010
[TBL] [Abstract][Full Text] [Related]
8. Integrated Phenotypic/Genotypic Analysis of Papillary Renal Cell Carcinoma Subtypes: Identification of Prognostic Markers, Cancer-related Pathways, and Implications for Therapy.
Saleeb RM; Plant P; Tawedrous E; Krizova A; Brimo F; Evans AJ; Wala SJ; Bartlett J; Ding Q; Boles D; Rotando F; Farag M; Yousef GM
Eur Urol Focus; 2018 Sep; 4(5):740-748. PubMed ID: 28753789
[TBL] [Abstract][Full Text] [Related]
9. Bioinformatics profiling integrating a four immune-related long non-coding RNAs signature as a prognostic model for papillary renal cell carcinoma.
Liu Y; Gou X; Wei Z; Yu H; Zhou X; Li X
Aging (Albany NY); 2020 Jul; 12(15):15359-15373. PubMed ID: 32716909
[TBL] [Abstract][Full Text] [Related]
10. Characterization of Clinical Cases of Advanced Papillary Renal Cell Carcinoma via Comprehensive Genomic Profiling.
Pal SK; Ali SM; Yakirevich E; Geynisman DM; Karam JA; Elvin JA; Frampton GM; Huang X; Lin DI; Rosenzweig M; Lipson D; Stephens PJ; Ross JS; Miller VA; Agarwal N; Shuch B; Choueiri TK; Chung JH
Eur Urol; 2018 Jan; 73(1):71-78. PubMed ID: 28592388
[TBL] [Abstract][Full Text] [Related]
11. Identification of a Two-m6A RNA Methylation Regulator Risk Signature as an Independent Prognostic Biomarker in Papillary Renal Cell Carcinoma by Bioinformatic Analysis.
Yang F; Zhao G; Ge L; Song Y; Hong K; Zhang H; Liu C; Hong P; Ma L
Biomed Res Int; 2021; 2021():4582082. PubMed ID: 33628782
[TBL] [Abstract][Full Text] [Related]
12. Screening and identification of key biomarkers of papillary renal cell carcinoma by bioinformatic analysis.
Xu Y; Kong D; Li Z; Qian L; Li J; Zou C
PLoS One; 2021; 16(8):e0254868. PubMed ID: 34358255
[TBL] [Abstract][Full Text] [Related]
13. A Prognostic Model Based on the Immune-related Genes in Colon Adenocarcinoma.
Sun YL; Zhang Y; Guo YC; Yang ZH; Xu YC
Int J Med Sci; 2020; 17(13):1879-1896. PubMed ID: 32788867
[No Abstract] [Full Text] [Related]
14. Proteomic analysis identifies HMGA2 as a novel biomarker of overall survival in papillary renal cell carcinoma.
Wei T; Xu H; Liang H; Lian Y; Chen H; Zheng Z; Zhong M; Liu J; Wang R; Wang F
Cancer Med; 2023 Jul; 12(13):14851-14864. PubMed ID: 37283291
[TBL] [Abstract][Full Text] [Related]
15. Transcriptome mapping of renal clear cell carcinoma revealed by machine learning algorithm based on enhanced computed tomography images.
Yang Y; Huang H; Liang H
J Gene Med; 2023 Jul; 25(7):e3494. PubMed ID: 36869574
[TBL] [Abstract][Full Text] [Related]
16. Identification of basement membrane-related prognostic signature for predicting prognosis, immune response and potential drug prediction in papillary renal cell carcinoma.
Xi Y; Song L; Wang S; Zhou H; Ren J; Zhang R; Fu F; Yang Q; Duan G; Wang J
Math Biosci Eng; 2023 Apr; 20(6):10694-10724. PubMed ID: 37322956
[TBL] [Abstract][Full Text] [Related]
17. In silico DNA methylation analysis identifies potential prognostic biomarkers in type 2 papillary renal cell carcinoma.
Yang M; Hlady RA; Zhou D; Ho TH; Robertson KD
Cancer Med; 2019 Sep; 8(12):5760-5768. PubMed ID: 31361072
[TBL] [Abstract][Full Text] [Related]
18. Identification of novel prognostic alternative splicing signature in papillary renal cell carcinoma.
Duan Y; Zhang D
J Cell Biochem; 2020 Jan; 121(1):672-689. PubMed ID: 31407370
[TBL] [Abstract][Full Text] [Related]
19. A pan-cancer perspective analysis reveals the opposite prognostic significance of CD133 in lower grade glioma and papillary renal cell carcinoma.
Wang H; Wang X; Xu L; Zhang J; Cao H
Sci Prog; 2021; 104(2):368504211010938. PubMed ID: 33878963
[TBL] [Abstract][Full Text] [Related]
20. Correlating Transcriptional Networks to Papillary Renal Cell Carcinoma Survival: A Large-Scale Coexpression Analysis and Clinical Validation.
Feng X; Zhang M; Meng J; Wang Y; Liu Y; Liang C; Fan S
Oncol Res; 2020 May; 28(3):285-297. PubMed ID: 31948514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]